Marketresearchnews

Thursday, 4 February 2021

Needle-Free Diabetes Care Market Expected To Boost During 2020 To 2023

Diabetes is a group of metabolic disorders, which is caused by insulin deficiency. Needle-free is a modern technique for administration of the medication to the patient. According to the International Diabetes Federation, about 420 million adult population was suffering from diabetes in 2016, which is increasing at the rate of 8.4% per year and is expected to reach 625 million by 2040. Increasing diabetic population is the major driving factor for the growth of the market. Moreover, increasing obese population, increasing healthcare expenditure, and strong encouragement from the government have also contributed to the growth of the market. According to research, smoking increases the possibility of diabetes; more than 60% of the global population smokes, this has increased the risk of diabetes and contributed to the growth of the market. On the other hand, factors such as, lack of awareness among people and higher cost are hampering the growth of the market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/912

Global needle-free diabetic care market is expected to grow at a CAGR of 7.5% during the forecast period 2017-2023.

Segmentation

The global needle-free diabetic care market is segmented on the basis of devices types into treatment devices and diagnostic devices. Treatment devices are further segmented: insulin jet injector, insulin pen, insulin inhaler, and insulin patch & pump. Diagnostic devices are also further segmented into continuous glucose monitoring and instant glucose monitoring. On the basis of treatment, the market is segmented into oral insulin, inhaled insulin, insulin patch, and others. On the basis of applications, the market is segmented into insulin delivery and others. On the basis of end users, the market is segmented into diagnostic centers, hospitals & clinics and other.

Regional Analysis

America dominates the global needle-free diabetes care market owing to large diabetic population. Apart from this, increasing number of obese people, changing lifestyle and increasing healthcare expenditure have boosted the growth of the market in America. Europe accounts for the second largest market, which is followed by Asia Pacific. Asia Pacific is the fastest growing region in the global market due to the presence of large diabetic population.

Key Players for Global Needle-free Diabetes Care Market

Antares Pharma, Inc. (US), Bioject Medical Technologies Inc. (US), Endo International plc (US), European Pharma Group (Netherland), PharmaJet (US), Medical International Technology, Inc. (US), Valeritas, Inc. (US), PenJet Corporation (US), INJEX Pharma AG (Germany), National Medical Products Inc. (US), Crossject SA (France), Zogenix, Inc. (US), 3M Company (US).

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/needle-free-diabetes-care-market-912

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Wearable Tracking Devices Market Expected To Boost During 2020 To 2023

The global wearable tracking devices market is expected to grow during the forecast period. The wearable tracking devices allow the users to monitor their health and physical activity. These devices can be worn on body 24*7, and the device continuously records your vitals accurately like heart rate, quality of sleep, step count and others. The growing trend of wearable fitness tracking device among the young generation is the key factor for the market to grow. Furthermore, the increasing prevalence of cardiovascular diseases, rising obesity rates, the rise of fitness consciousness among the old population, increasing demand for sophisticated technology devices, and modernization of lifestyle fuel the market growth.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/902

Segmentation

However, factors such as high costs of wearable tracking devices, security issues, and different devices give different results are some of the factors expected to hinder the market growth during the forecast period.

Segmentation

The global wearable tracking devices market is segmented on the basis of types, application, sales channel, and end-user. The global wearable tracking devices market, by type, is segmented into Wristwear, Footwear and other. The wristwear segment includes Fitness Bands and Smartwatch. The Application segment is segmented into Healthcare, Consumer electronics, and others. Sales Channel segment consists of online and offline. On the basis of end-user, the market is categorized into Sportsperson, Patients, and Others. On the basis of region, the Global wearable tracking devices Market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.

Key players

Some of the key players for the Global wearable tracking devices Market are Adidas (Germany), Gramin Ltd (Switzerland), Apple Inc (US), Pebble Technology Corp (US), Samsung Electronics Co Ltd (South Korea), Sony (Japan), Fitbit, Inc. (US), Google Inc. (US), Xiaomi Technology Co., Ltd. (China), Jawbone (US), Nike (US).

Regional Market Summary

The wearable tracking devices market is dominated by North America owing to rising cardiovascular diseases in this region. According to the CDC in 2015, 366,000 people died due to heart disease.

The presence of major market players such as Apple, Nike, and Jawbone in this region also influences the market growth.

It is estimated that Europe stood second in the global wearable tracking devices market. The rising obesity in this region is driving the growth of the market. In the EU, 51.6 percent of people are overweight. Thus, this enhances the global wearable tracking devices Market in this region.

The Asia Pacific will witness growth for the wearable tracking devices market owing to the trend of wearable fitness tracking device among the young generation. China, India, and Japan are key market players in this region and is expected to be the largest market for the wearable tracking devices. India has 60% of the young population below 35 years. Thus, this provides favorable backgrounds for the market to grow.

The Middle East and Africa holds the least share in the Global wearable tracking devices Market due to the presence of stringent government policies and poor economies.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/wearable-tracking-devices-market-902

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Human Insulin Market Segmentation Detailed Study With Forecast Up To 2023

With the global prevalence of diabetes expanding significantly, the global human insulin market is expected to grow at a compound annual growth rate of 12.5% over the forecast period of 2017-2023, proclaims Market Research Future (MRFR) in a meticulously analyzed research report. Change in lifestyle and high prevalence of obesity is the root cause of widespread occurrence of diabetes which induces demand for human insulin. The rise in the global geriatric population who are at more risk of suffering from diabetes coupled with raising awareness of diabetes boosts the growth of the global human insulin market. Growing emphasis on diabetes management and technological advancement of insulin delivery devices such as the introduction of insulin pens have added fuel to ten growth of the market. The rise in a number of clinical trials for the development of novel therapies and treatment for diabetes purveyed by investment from pharmaceuticals companies has been a plus for the market growth. However, the soaring price of human insulin, manufacturing complexities and complicated regulatory process for the approval of new drugs impede the growth of the market. Additionally, loss of patent acts as a major deterrent to the market growth. Development of biosimilars is a significant trend which is expected to increase the competition in the market and in turn, boost the market growth

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/849

Segmentation

The global human insulin market has been segmented based on type, methods, indication, and end users. By type, the market has been segmented into accessories and devices. By methods, the market has been segmented into traditional human insulin and modern human insulin. By indication, the market has been segmented into type 1 diabetes and type 2 diabetes. By end users, the market has been segmented into hospitals, forensic laboratories, research centers, and others.

Regional Analysis

The global human insulin market spans across the regions of the Americas, Europe, Asia Pacific, and the Middle East & Africa. North America accounts for the largest share of the global human insulin market owing to high health care spending, the presence of major players in the region who invest more money in R&D activities and inclination towards quality healthcare. The US is the largest market in the region followed by Canada while South America is expected to be the fastest growing region. The Europe market for human insulin is strong and is driven by the presence of a large pool of patients and the availability of funds for research and development in countries such as Germany. Asia Pacific market growth is supported by the presence of a vast patient base and rising prevalence of diabetes in the region. Improvement in healthcare infrastructure in countries such as China, India, and Japan is key to the growth of the market. Moreover, Asia Pacific hosts a huge geriatric population who are at more risk of acquiring diabetes. The Middle East & Africa market is expected to exhibit steady growth over the forecast period. Countries such as United Arab Emirates (U.A.E.), Saudi Arabia, and Oman have a robust healthcare infrastructure which drives the market in the Middle East while in Africa, weak economic conditions and under-developed healthcare sector deters the growth of the market.

Competitive Landscape

The notable players operating in the global human insulin market include Biocon Ltd, ADOCIA, Julphar, Bristol-Myers Squibb Company, Oramed Pharmaceuticals, Inc, Sanofi, Tonghua Dongbao Pharmaceuticals Co., Ltd., Merck & Co, Pfizer, Inc, GlaxoSmithKline, and Novo Nordisk A/S.

Industry Updates

In August 2018, Monarch Medical Technologies, a leading provider of electronic systems for inpatient glycemic management received US patent for its approach to inpatient insulin therapy. The approach has already been granted class II FDA clearance and underlines the uniqueness of the EndoTool technology.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/human-insulin-market-one-849

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Maternal health Market To Observe Strong Development By 2023

The maternal health market is growing steadily. The complications are seen in more number in the pregnant ladies. These complications are of higher risk and are occurring to the changing lifestyle and trends among the women. The habits of smoking and drinking seen is more now a days. The study says that 1 women in 3 smokes during first three months of her pregnancy. In developed countries and urban areas of developing countries number of women who smoke is more. In developing countries women between the ages of 15-19 dies because of complications during pregnancy and child birth. The number of deaths is also increasing after the delivery of baby, both women and child suffer from the diseases. The postpartum deaths are seen within the one month of delivery. The number of deaths are also more because of the miscarriage taking place to accidents, unhealthy eating habits and the habits of smoking and alcohol consumptions. The complication are also created by these habits, child is born with the disability in his body.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/732

Global Maternal Health market Players:

Some of the players who work maternal health are, Agile Therapeutics (USA), Fuji Latex Co(Japan), Okamoto industries, Reckitt Benckiser Group Plc.(UK), Sanofi (India), Johnson and Johnson(USA).

Agile therapeutics is women healthcare company, have announced the report of the additional phase 3 SECURE study research report for women healthcare. The Phase 3 SECURE trial of its investigational low-dose combination hormone contraceptive patch of Twirla. This product will be used for the bleeding in women.

Johnson and Johnson is actively working with the Millennium Development Goals (MDG). The millennium Development Goals is a caring and serving community working for the women and children. The main objective of this to reduce the mortality rate. They aim to help as many as women every year approximately 120 million will be get help in next 5 years. They also aim to reach 50 countries through their programs.

Sanofi India, is also a part of MDG and is trying to help women caring and providing services through their corporate social responsibility. The employees are constantly involved in volunteering and contributing of the women in India. They work in collaboration with organizations like Indian Medical Association and Pharmaceutical industry and many more.

Taste the market data and market information presented through more than 50 market data tables and figures spread over 80 numbers of pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Global Maternal Health Market” Research Report – Forecast to 2023.

Segmentation:

The market of the maternal health is segmented into type of the pregnancy, risk in pregnancy and complications. Types of pregnancy includes Intrauterine, Ectopic, Tubal and Others. On the basis of risk occurred in pregnancy which have high risk and molar risk. On the basis of the complications like miscarriage, premature labor and birth, preeclampsia, gestational diabetes, placenta previa and others. The miscarriage further have sub segments like threatened, inevitable, complete, and incomplete. The type of pregnancy have larger market because the number of women getting pregnant is more. The number adolescent age women are more. The number is high in the developing countries where the marriages are done at early ages.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/maternal-health-market-732

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Paresthesia Treatment Market To Observe Strong Development By 2023

Paresthesia is an abnormal sensation of the skin such as numbness, burning, pricking, and many other. On the basis of severity, they are acute or chronic. Some of the major causes of for the diseases are vitamin deficiency, hyperventilation syndrome, or by the use of anesthesia. The global paresthesia treatment market is majorly driven by increasing prevalence of the paresthesia, changing lifestyle and poor diet. Furthermore, development in the healthcare expenditure, the government support for the research & development for new and better treatment have fuelled the market growth. However, lack of effectiveness and unavailability of precise treatment may hinder the market growth over the forecasted period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/719

Global Paresthesia Treatment market is expecting a healthy growth at a CAGR of 7.2 % during the forecast period 2017-2013.

Segmentation

The global paresthesia treatment market is segmented on the basis of types, treatments, and end users. On the basis of types, the market is segmented into acute paresthesia, chronic paresthesia. On the basis of treatment, the market is segmented into immunosuppressant, anticonvulsants, topical creams, antivirals, and others. Immunosuppressant is further classified into prednisone, intravenous gamma globulin, and others. Topical creams are further classified into lidocaine, prilocaine, and other. On the basis of end users the market is segmented into hospitals, clinics, diagnosis centers, and others.

Regional analysis

America dominates the global paresthesia treatment market owing to the presence of a large number of patients with paresthesia and well developed technology. Furthermore, the government support for the research & development, and high healthcare expenditure have supported the growth of the market. Europe accounts for the second largest market, which is followed by Asia Pacific. Asia Pacific is the fastest growing market due to the presence of the huge opportunities in the market. India and China is the major contributor to the market owing to the presence of huge population base and rapidly growing economies. The Middle East & Africa holds the lowest share in the market.

Key players

Some of the major players in the global paresthesia treatment market are Medtronic (UK), Omron Healthcare, Inc. (US), Boston Scientific Corporation (US), Stimwave LLC, (US), Nevro Corp. (US), Cyberonics, Inc. (US), EnteroMedics Inc. (US), St. Jude Medical, LLC. (US), Bio-Medical Research Ltd. (UK), Baxter (US), Stryker (US), GlaxoSmithKline plc.(UK).

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/paresthesia-treatment-market-719

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Protein Engineering Market To Observe Strong Development By 2024

Proteins, the building blocks of the body, are large biomolecules made up of amino acids. They perform various functions such as DNA replication, catalyzing metabolic reactions, transporting molecules from one location to another, and responding to stimuli. Furthermore, proteins also have a wide range of applications in the diagnosis of disease and treatment development. Protein engineering involves designing and constructing new proteins by modifying amino acid sequences to produce enzymes and desired properties and the synthesis of proteins with a particular structure. This technology helps us to understand the basics of how enzymes function and have evolved, and it is the key method of improving enzyme properties for applications in pharmaceuticals, green chemistry, and biofuels.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/684

The major objective of protein engineering is to produce biological compounds which include a synthetic peptide, storage protein, and synthetic drugs which will be superior to a normal one and create an enzyme which is superior in its properties to produce high-value chemicals in large quantities.

The global protein engineering market is driven by the increasing demand for new technologies having their application in healthcare and by the growth in research and development activities for improving health outcomes using novel technologies. Furthermore, the emergence of trends in protein identification and tracking and the increasing use of protein studies in research activities drive the growth of this market. However, there are various factors that may hinder the growth of the market such as expensive instruments used in protein engineering that require huge maintenance and lack of trained personnel.

Global market for protein engineering is expected to grow at a CAGR of approximately 6.2% during the forecast period 2017–2023.

Intended Audience

Healthcare companies
Contract Research Organizations (CROs)
Research and Development (R&D) companies
Academic medical institutes and universities

Segmentation:

The global protein engineering market is segmented to the basis of type, method, application, and end-users.

On the basis of type, the market is segmented into instrument, reagents, and services and software.

On the basis of method, the market is segmented into rational protein design and directed evolution.

On the basis of application, the market is segmented into food and detergent industries, environment applications, medical applications, biopolymer production, and nanobiotechnology.

On the basis of end-user, the market is segmented into academic research institutes, pharmaceuticals and biotechnology companies, and contract engineering organizations.

Regional Analysis

Globally, protein engineering market consists of four regions, namely, Americas, Europe, Asia Pacific, and the Middle East and Africa. North America is the largest market owing to the concentration of major market players and increase in a number of biotechnology and pharmaceutical companies. The U.S. is the largest market in North America followed by Canada. In the U.S., extensive protein engineering technologies and methods and availability of technologically-advanced devices and instruments for research also drive the growth of the market.

Europe is the second largest market for protein engineering which is majorly driven by the increasing demand for protein engineering methods and technologies and the overall growth of research and development sector in major countries such as Germany, the U.K., and France. Furthermore, the growth in funding for protein engineering and emphasis on drug discovery are other factors expected to drive the growth of the market during the review period.

Asia Pacific shows the fastest growth which is driven by the rising prevalence of lifestyle diseases such as heart diseases, diabetes, obesity, and others and need for new technologies with their application in healthcare.

The Middle East and Africa shows a steady but positive growth with an increase in the demand for new drugs and devices for diagnosis and the treatment of diseases and improvement in healthcare infrastructure.

Key Players

Agilent Technologies (U.S.), AB-Sciex (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Bruker Corp. (U.S.), GE Healthcare (U.K.), Perkin Elmer (U.S.), Sigma-Aldrich Corp. (U.S.), Thermo Fisher Scientific (U.S.), and Waters Corp. (U.S).

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/protein-engineering-market-691

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Microfluidics Device Market Segmentation Detailed Study With Forecast Up To 2024

A microfluidic device is well accepted technology and has several applications. The technology allows integration of many medical tests on a single chip. It has become an essential technology for integration, industrialization, miniaturization and parallelization of various tests in the fields of diagnostics, drug development and biological research. The technology also helps in reducing the side effects and improving the efficacy of treatment. New microfluidic methods are used for evaluating drugs and manipulating cells for the treatment of diseases related to heart and cancer.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/684

Globally, the market for microfluidic devices is gaining significant importance due to growing R&D investment in life sciences, pharmaceuticals, increasing point of care testing demand and An increase in point of care testing, as an effective method for delivery of treatment, has also led to increase in the demand for microfluidic devices in the global market

Some other factors driving the microfluidic devices market are rise in the commercial and analytical application of these devices and use of microfluidic products for miniaturization of chip.

Moreover some of the challenges faced by the market are adherence to stringent regulatory requirements to decelerate growth and geometrical and surface chemistry issues.

The use of microfluidic devices has been gaining importance into recent classification of research areas that target integration of laboratory protocols into miniaturized devices known as lab on chip.

This process includes many steps such as mixing, pre-treatment, reaction, separation, and pre-concentration. These processes help to reduce the cost and consume less reagent/sample, which is further helpful in various medical diagnosis with the help of blood drop. The miniaturization technique is expected to drive the microfluidic devices market, as this technique helps to reduce the overall cost of screening the compounds for cell biology problems by the pharmaceutical companies. Also the miniaturization technique helps in the reduction of analysis time and carry parallel assay in microfluidic devices, which is further expected to support the growth of this market.

Competitive Analysis:

Hoffmann-la Roche AG, Abbott laboratories, Siemens healthcare GMBH, Agilent technologies, Inc., Fluidigm corporation, bio-rad laboratories, ink, Cepheid, Raindance technologies, Inc., Dolomite centre, Micronit microfluidics, Johnson & Johnson, Becton, Dickinson and Company, These are some of the prominent players at the forefront of competition in the Global Microfluidic Devices Market.

Global Microfluidics Device Regional Analysis:

North America is the largest market for microfluidic devices, with factors such as growing old age population, increasing healthcare awareness, rising chronic and lifestyle diseases, technological developments for various home use applications and wider insurance infrastructure facilities driving the growth of microfluidic devices. With the rise in overall healthcare expenditure, the use of these devices has increased, since these devices provide accurate, reliable and quick results for early detection and prevention of diseases.

Due to its early introduction and wider applications in industries, use of microfluidic devices is high in North America as compared to other geographies. According to the European Federation of Pharmaceutical Industries and Associations, in 2014, the North American pharmaceutical market accounted for about 41.0% share of the global pharmaceutical market. High research and development expenditures in new drug lead to increase in the demand for various microfluidic devices for toxicity testing in the drug development process.

The European market for microfluidic devices is driven by increasing diagnostic requirements, due to rise in lifestyle associated diseases and increasing geriatric population. On the other hand, the increasing healthcare expenditure in the region has led to a shift in the focus of healthcare from hospitals to home, leading to increased use of microfluidic devices in the region.

According to the European Federation of Pharmaceutical Industries and Associations, R&D investment in Europe was about $40.2 billion, which lead to increased production of drugs in pipeline. The use of microfluidic devices is also expected to increase microreactors in drug synthesis and toxicity testing in drug development.

There are various regulatory issues related to microfluidic devices used for pharmaceutical research, point of care testing and clinical and veterinary diagnosis. The European Medical Devices Directives regulates the laws on performance and safety of the medical devices

In Asia, there has been an overall increase in the clinical outcomes and patient requirement, due to availability of specific and sensitive diagnostic tests, along with technologically advanced medical equipment and devices. At the back of this trend, Asia has become an attractive market for medical device companies.

Lately, China has become has come up as one of the fastest growing markets for microfluidics in Asia due to increased government funding and improving healthcare facilities.

Asian countries have different regulatory bodies for medical devices. In Japan, the Ministry of Health Labour and Welfare (MHLW) is responsible for the Japanese Pharmaceutical Affairs Law (JPAL) and regulates all medical devices manufactured or sold. Similarly in China, the State Food and Drug Administration (SFDA) is under the State Council, and is responsible for the supervision of the safety management of food, cosmetics and health food.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/microfluidics-device-market-684

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com